Home
About WorldWIDE
Education
Evidence of the Month
Diabetes Myths & Facts
Role of diabetes education
Case studies
Patient communication tools
Viewpoints
Publications
Slide resource
Congresses
and Events
Newsletters

 
Home > Evidence of the Month
Education
Evidence of the Month

Return to education homepage

Commentaries on both new and classic studies of importance for the treatment of diabetes are posted here monthly.

Click here to view the archive of past commentaries.


The RECORD Study of Rosiglitazone and Cardiovascular Risk

Alan Vaag
Steno Diabetes Center
Gentofte, Denmark

Comment on:
Home PD, Pocock SJ, Beck-Nielsen H, et al, for the RECORD Study Team. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet. 2009;373:2125-2135.

Diagnosis of Diabetes: The Case for Use of the HbA1c

Petra-Maria Schumm-Draeger
Klinik für Endokrinologie,
Diabetologie und Angiologie
Klinikum Bogenhausen
Munich, Germany

Comment on:
The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327-1334.
 

 

This Website Feature is funded by an educational grant from Bristol-Myers Squibb/AstraZeneca.

Return to homepage

 

 

   Submit a link?

Print this page
   
  Add to Favourites
   

Top of page | Home